Thrombotic microangiopathy: COVID-19 or hydroxychloroquine? | Kidney Int;98(6): 1619-1620, 2020 12. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?

Hasbal, Nuri Baris.

Hasbal NB; Hakkari State Hospital, Department of Nephrology, Hakkari, Turkey. Electronic address: nbhasbal@gmail.com.

Kidney Int ; 98(6): 1619-1620, 2020 12.

Article in English | MEDLINE | ID: covidwho-795168

Subject(s)

COVID-19; Thrombotic Microangiopathies; Humans; Hydroxychloroquine/adverse effects; Pandemics; SARS-CoV-2; Thrombotic Microangiopathies/chemically induced; Thrombotic Microangiopathies/diagnosis; Thrombotic Microangiopathies/epidemiology

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombotic Microangiopathies / COVID-19 Type of study: Diagnostic study / Observational study Limits: Humans Language: English Journal: Kidney Int Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombotic Microangiopathies / COVID-19 Type of study: Diagnostic study / Observational study Limits: Humans Language: English Journal: Kidney Int Year: 2020 Document Type: Article